TSTickerStar
Company alerts/XBIO
XBIO company alerts

XBIO updates worth following

TickerStar monitors official filings, investor releases, earnings, and call updates for XBIO. Subscribe to XBIO alerts to receive concise, source-linked alerts when TickerStar detects a meaningful company update.

Official-source feed

Recent XBIO alert previews

TickerStar filters routine noise and surfaces investor-relevant filings, releases, earnings, and call updates.

SEC filingSEC filing

XBIO 10-Q filed 2026-11-12 | Key takeaways

XBIO filed its 10-Q; the most relevant disclosure change is added Business combinations: Xenetic entered into a Share Exchange Agreement on September 14, 2026 to acquire Santersus AG, a Swiss biotech company focused on NET-targeting technologies, with Santersus shareholders expected to own approximately 85% of the combined company post-closing and. Customer concentration: Takeda Pharmaceutical Co. Ltd. represented 100% of revenue.

Read source-backed brief